K-BROVET 250- potassium bromide tablet, chewable

País: Estats Units

Idioma: anglès

Font: NLM (National Library of Medicine)

ingredients actius:

POTASSIUM BROMIDE (UNII: OSD78555ZM) (BROMIDE ION - UNII:952902IX06)

Disponible des:

Pegasus Laboratories, Inc.

Designació comuna internacional (DCI):

POTASSIUM BROMIDE

Composición:

POTASSIUM BROMIDE 250 mg

Vía de administración:

ORAL

tipo de receta:

PRESCRIPTION

indicaciones terapéuticas:

Anticonvulsant K●BroVET® should not be used in animals with a history of hypersensitivity to Bromide or any of the com-ponents of the solution or tablets.

Resumen del producto:

250mg Tablet (60ct) bottle NDC 49427-322-48

Estat d'Autorització:

unapproved drug other

Fitxa tècnica

K-BROVET 250- POTASSIUM BROMIDE TABLET, CHEWABLE
PEGASUS LABORATORIES, INC.
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
CAUTION:
Federal law restricts this drug to use by or on the order of a
licensed veterinarian. Contains a new
animal drug for use only in investigational animals in clinical
trials. Not for use in humans. Edible
products of investigational animals are not to be used for food unless
authorization has been granted by
the U.S. Food and Drug Administration or by the U.S. Department of
Agriculture.
Rev. 10-2015
PRODUCT INFORMATION
SEE WARNINGS CONCERNING USE IN ANIMALS WITH CERTAIN CONDITIONS.
DESCRIPTION
K●BroVET® Chewable Tablets are liver flavored tablets containing
250 mg or 500 mg of potassium
bromide and cyanocobalamin.
INDICATIONS :
Anticonvulsant
HOW SUPPLIED:
250mg Tablet (60ct) bottle
NDC 49427-322-48
STORAGE CONDITIONS:
Store in a tightly sealed container at room temperature (59-86F).
KEEP OUT OF REACH OF CHILDREN AND ANIMALS.
INDICATION
K●BroVET® potassium bromide is used to treat seizure disorders in
dogs. It can be used in addition to
therapy with other agents or as the sole anticonvulsant.
CONTRAINDICATIONS
K●BroVET® should not be used in animals with a history of
hypersensitivity to Bromide or any of the
com-ponents of the solution or tablets.
DOSAGE AND ADMINISTRATION
RECOMMENDED DOSAGE FOR K●BROVET® ORAL SOLUTION AND TABLETS:
To achieve a serum level of approximately 1 mg/mL, give 120 mg/kg PO
daily for 5 days then reduce to
30mg/kg PO once daily. To achieve a serum level of approximately 1.5
mg/mL, give 160 mg/kg PO for
5 days and then reduce to 40 mg/kg PO once daily thereafter.
Among dogs responses to bromide may vary, treatment should be tailored
to the individual dog, based
on serum bromide concentration, success of seizure control, and the
observation of adverse effects.
Steady state serum concentrations generally